Sign in
CompletedNo phase

Efficacy and Safety of the Soricle for Subjective Tinnitus Relief

Key facts

Who runs it
Neurive Co.,Ltd.
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
36 people enrolled
Started
10 Mar 2025
Ended
8 Sept 2025
Type of study
Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Sham Device
  • tVNS Device
  • tVNS + Sound Stimulation Device
Record updated
23 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adults aged 18 years or older
  • Patients with subjective tinnitus
  • Able to understand and provide informed consent
  • Willing to comply with study procedures

Who cannot take part

  • History of neurological or psychiatric disorders that may affect study outcomes
  • Any condition that, in the investigator's judgment, may interfere with study participation
  • Objective tinnitus
  • Severe hearing loss requiring immediate treatment
  • Use of other tinnitus treatments during the study period

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study was conducted to evaluate the efficacy and safety of Soricle, a medical device combining transcutaneous vagus nerve stimulation and sound stimulation, in patients with subjective tinnitus.

Read full original descriptionShow less

Participants were randomly assigned to either the active treatment group or a sham control group in a double-blind manner. The device was used daily for 8 weeks.

The primary objective was to assess the improvement in tinnitus symptoms, and safety was evaluated throughout the study period.

The 3 groups in the trial

  • Sham ComparatorSham treatment, for comparison

    Participants received a sham device identical in appearance to the active device but without delivering therapeutic stimulation.

    Treatment: Sham Device

  • tVNS StimulationTreatment being tested

    Participants received transcutaneous vagus nerve stimulation (tVNS) using the investigational device.

    Treatment: tVNS Device

  • tVNS + Sound StimulationTreatment being tested

    Participants received combined transcutaneous vagus nerve stimulation (tVNS) and sound stimulation using the investigational device.

    Treatment: tVNS + Sound Stimulation Device

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of the Soricle, a Class III Combination Device of Vagus Nerve Stimulation and Sound Stimulation, for Subjective Tinnitus Relief: A Prospective, Single-Center, Randomized, Double-Blind, Sham-Controlled, Exploratory Clinical Trial
Record updated
23 April 2026